Revitalizing Maternal Health: Nonprofit Leverages Low-Dose Aspirin to Combat Preeclampsia Disparities
GAP—SPIRIN Initiative:
The Preeclampsia Foundation, in partnership with Patients & Purpose, launched GAP—SPIRIN, an evidence-based education campaign aimed at promoting the use of low-dose aspirin to prevent preeclampsia and close the maternal health equity gap4.
Preeclampsia Disparities:
Black mothers are 60% more likely to develop preeclampsia, a serious hypertensive disorder that poses life-threatening risks during pregnancy and the postpartum period4.
Low-Dose Aspirin:
Early use of low-dose aspirin in pregnancy can reduce the risk of preeclampsia, yet many Black women are not informed about this preventive measure4.
Community Focus:
GAP—SPIRIN initially targets five New York City zip codes with high risks for preeclampsia and maternal mortality, primarily serving Black populations4.
Healthcare Provider Engagement:
The campaign includes educating healthcare providers about disparities and the use of low-dose aspirin as a preventative treatment for preeclampsia, aiming to improve maternal health outcomes4.
Broader Impact:
The initiative aims to address systemic barriers and promote health equity by integrating women’s voices and perspectives into healthcare policies and practices2.
Global Context:
Efforts like GAP—SPIRIN align with broader global initiatives to accelerate innovation in maternal health, such as the Accelerating Innovation for Mothers (AIM) project, which focuses on developing new medicines for pregnancy-specific conditions15.
Sources:
1. https://www.conceptfoundation.org/accelerating-innovation-for-mothers/
2. https://www.msdformothers.com/docs/MSD-MfM-Brief-Maternal-Health-Equity.pdf
4. https://www.prnewswire.com/news-releases/preeclampsia-foundation-launches-gapspirin-a-creative-intervention-for-black-maternal-health-302358047.html
5. https://www.conceptfoundation.org/concept-foundation/accelerating-innovation-for-mothers-aim-initiative-develops-four-new-target-product-profiles-for-prevention-and-treatment-of-preeclampsia-and-preterm-labour/